October 23, 2024

CEO Featured on Radio NIKKEI

We’re excited to share that our CEO, Takehara, was featured on Radio NIKKEI’s program, Leaders in...
Read More
October 7, 2024

Selected as a Finalist for the CITELINE Japan Award 2024 Biotech Company of the Year

We are honored to announce that we’ve been chosen as a finalist for the prestigious Biotech...
Read More
September 30, 2024

Notice of Article Published in the Nikkei

Prism BioLab in the Spotlight for Drug Discovery, Recognized by Major Pharma www.nikkei.com/article/DGXZQOUC06CAK0W4A900C2000000/
Read More
September 9, 2024

Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting

TOKYO, Japan, 9 September 2024: -- PRISM BioLab, Co. Ltd. , a leading discovery and development...
Read More
September 2, 2024

PRISM BioLab opens a business office in Tokyo

We are pleased to announce the establishment of PRISM BioLab Co., Ltd. Tokyo office. The office...
Read More
July 2, 2024

Announcement of Initial Listing on Tokyo Stock Exchange Growth Market

PRISM BioLab Corporation is pleased to announce its initial listing on the Tokyo Stock Exchange Growth...
Read More
May 27, 2024

Notice of Approval for Listing on the Growth Market of the Tokyo Stock Exchange

PRISM BioLab is pleased to announce that the Tokyo Stock Exchange today approved the initial listing...
Read More
April 25, 2024

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

TOKYO, Japan, 25 Apr 2024: -- PRISM BioLab, Co. Ltd. , a leading discovery and development...
Read More
April 21, 2024

Announcement of setting the record date for stock split

Announcement of setting the record date for stock split（pdf）
Read More
January 24, 2024

PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions

TOKYO, Japan, 24 Jan 2024: –PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology...
Read More
1 2 3